SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.270+1.2%11:45 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RoadyHD who wrote (12564)12/19/2019 4:59:05 PM
From: HardToFind   of 12873
 
If they get equity underwritten for that latest S-1 and also get some debt financing, and Diwan makes his bridge loan convertible, it might be just enough. But I don't think it's likely.
You're welcome here, but wasting your time looking for an attractive buy price on the stock. Unless someone puts a gun at the head of Diwan, his deal to screw the shareholders stands. If you want to get a deal, stay away from common shares. Or you can speculate in the prospect of a bigger fool showing up to buy shares...but that didn't turn out well for me. The word is getting out about what you're dealing with in Diwan.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News